Cargando…

Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors

Initially developed as glucose-lowering drugs, sodium-glucose co-transporter type 2 inhibitors (SGLT2i) have demonstrated to be effective agents for the risk reduction of cardiovascular (CV) events in patients with type 2 diabetes mellitus (T2DM). Subsequently, data has emerged showing a significant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Margonato, Davide, Galati, Giuseppe, Mazzetti, Simone, Cannistraci, Rosa, Perseghin, Gianluca, Margonato, Alberto, Mortara, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895775/ https://www.ncbi.nlm.nih.gov/pubmed/32901315 http://dx.doi.org/10.1007/s10741-020-10024-2

Ejemplares similares

Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population
por: Ciardullo, Stefano, et al.
Publicado: (2021)

Compassionate use of ruxolitinib in patients with SARS‐Cov‐2 infection not on mechanical ventilation: Short‐term effects on inflammation and ventilation
por: Mortara, Andrea, et al.
Publicado: (2021)

Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition
por: Margonato, Davide, et al.
Publicado: (2020)

Short‐term echocardiographic evaluation by global longitudinal strain in patients with heart failure treated with sacubitril/valsartan
por: Mazzetti, Simone, et al.
Publicado: (2020)

NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population
por: Ciardullo, Stefano, et al.
Publicado: (2022)

Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review
por: Rabizadeh, Soghra, et al.
Publicado: (2019)

Tricuspid Regurgitation in Left Ventricular Systolic Dysfunction: Marker or Target?
por: Margonato, Davide, et al.
Publicado: (2021)

SGLT2is and Renal Protection: From Biological Mechanisms to Real-World Clinical Benefits
por: Leoncini, Giovanna, et al.
Publicado: (2021)

Stress echocardiography in heart failure
por: Agricola, Eustachio, et al.
Publicado: (2004)

Transcatheter therapies for secondary mitral regurgitation in advanced heart failure: what are we aiming for?
por: Scotti, Andrea, et al.
Publicado: (2021)

Acute Heart Failure Caused by Parvovirus B-19 Myocarditis Treated with Human Immunoglobulin
por: Alberti, Luca, et al.
Publicado: (2012)

Peripheral artery disease and all-cause and cardiovascular mortality in patients with NAFLD
por: Ciardullo, S., et al.
Publicado: (2022)

Aortic Valvuloplasty as Bridging for TAVI in High-Risk Patients with Heyde's Syndrome: A Case Report
por: Godino, Cosmo, et al.
Publicado: (2012)

Acute Pulmonary Edema Caused by a Giant Atrial Myxoma
por: Fisicaro, Andrea, et al.
Publicado: (2013)

A Unique Case of Mitral Valve Double Papillary Muscle Rupture
por: Pannone, Luigi, et al.
Publicado: (2019)

Differential Association of Sex Hormones with Metabolic Parameters and Body Composition in Men and Women from the United States
por: Ciardullo, Stefano, et al.
Publicado: (2023)

SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists
por: Abdelgadir, Elamin, et al.
Publicado: (2018)

Surgical Single Stage Treatment for Obstructive Hypertrophic Cardiomyopathy and Aortic Arch Aneurysm
por: Margonato, Davide, et al.
Publicado: (2020)

Oral direct thrombin inhibition: a double-edged sword?
por: Fragasso, Gabriele, et al.
Publicado: (2015)

Multivessel coronary artery disease: atheroma progression and dynamic component
por: Cappelletti, A, et al.
Publicado: (2009)

Coronary angiography and angioplasty in a patient with an iliac artery volvolus
por: Franzoni, I, et al.
Publicado: (2010)

Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?
por: Belli, Martina, et al.
Publicado: (2023)

Novel therapeutic and diagnostic management of heart transplant patients
por: D'Addio, Francesca, et al.
Publicado: (2015)

Culture of the Aspirated Coronary Thromboembulus Specimen: A Peculiar Diagnostic Method for Infective Endocarditis
por: Slavich, Massimo, et al.
Publicado: (2013)

Massive Spontaneous Subcutaneous Emphysema and Pneumomediastinum as Rare Complications of COVID-19 Pneumonia
por: Di Maio, Silvana, et al.
Publicado: (2022)

Benefits of SGLT2 inhibitors in arrhythmias
por: Gao, Jinghan, et al.
Publicado: (2022)

Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy
por: Ciardullo, S., et al.
Publicado: (2020)

Renal and Cardiovascular Metabolic Impact Caused by Ketogenesis of the SGLT2 Inhibitors
por: Vargas-Delgado, Ariana P., et al.
Publicado: (2023)

Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors: Benefits in Diabetics With Cardiovascular Disease
por: Aftab, Saba, et al.
Publicado: (2020)

Serum neurofilament light chain levels are associated with all-cause mortality in the general US population
por: Ciardullo, Stefano, et al.
Publicado: (2023)

Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence-
por: Godino, Cosmo, et al.
Publicado: (2021)

Left atrial appendage occlusion after thromboembolic events or left atrial appendage sludge during anticoagulation therapy: Is two better than one? Real‐world experience from a tertiary care hospital
por: Margonato, Davide, et al.
Publicado: (2023)

DELIVER: Extending the benefits of SGLT-2 inhibitors
por: Samaan, Kerollos, et al.
Publicado: (2023)

Multi-omics insights into potential mechanism of SGLT2 inhibitors cardiovascular benefit in diabetic cardiomyopathy
por: Xi, Yangbo, et al.
Publicado: (2022)

Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers
por: Gessner, Arne, et al.
Publicado: (2022)

Off-Patent Generic Medicines vs. Off-Patent Brand Medicines for Six Reference Drugs: A Retrospective Claims Data Study from Five Local Healthcare Units in the Lombardy Region of Italy
por: Colombo, Giorgio L., et al.
Publicado: (2013)

Soluble α-Klotho levels, glycemic control and renal function in US adults with type 2 diabetes
por: Ciardullo, Stefano, et al.
Publicado: (2022)

Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
por: Bailey, Clifford J., et al.
Publicado: (2022)

Targeting Alcohol Septal Ablation in Patients with Obstructive Hypertrophic Cardiomyopathy Candidates for Surgical Myectomy: Added Value of Three-Dimensional Intracoronary Myocardial Contrast Echocardiography
por: La Canna, Giovanni, et al.
Publicado: (2021)

Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry
por: Paolisso, Pasquale, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2pdjd5bgdnthjacp2rkmk43r2d